Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 3 19Phase 1/2 11Phase 1 11Phase 2/3 4Phase 4 2Phase EARLY_PHASE1 1

Status

Recruiting 4Completed 3Active not recruiting 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 22pembrolizumab 17Drug Therapy 16Carboplatin 15Paclitaxel 12Dexamethasone 12Gemcitabine 11Magnetic Resonance Spectroscopy 10Bevacizumab 10Docetaxel 9venetoclax 8atezolizumab 8Pemetrexed 8Oxaliplatin 8Specimen Handling 7Radiotherapy 7Nivolumab 7Cyclophosphamide 7Capecitabine 7Methotrexate 6130-nm albumin-bound paclitaxel 6durvalumab 5blinatumomab 5Cytarabine 5Androgen Antagonists 5tislelizumab 4spartalizumab 4pertuzumab 4Vincristine 4Trimethoprim, Sulfamethoxazole Drug Combination 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Recruiting × Taxes × Clear all
NCT06203600 2026-05-26

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

National Cancer Institute (NCI)

Phase 2/3 Recruiting
224 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

NCT06783140 2025-12-05

PLATINUM-CAN

University Health Network, Toronto

Phase 2/3 Recruiting
10 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT06037980 2025-02-17

PURITY

Gruppo Oncologico del Nord-Ovest

Phase 2/3 Recruiting
300 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT06288373 2024-10-30

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Tongji Hospital

Phase 2/3 Recruiting
440 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡